ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Innate Pharma

Innate Pharma (IPH)

1.708
-0.004
(-0.23%)
終了 1月26日 1:30AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
1.708
買値
1.70
売値
1.73
出来高
38,761
1.702 日の範囲 1.728
1.332 52 週間の範囲 2.79
時価総額
前日終値
1.712
始値
1.724
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
155,823
発行済株式数
318,170,508
配当利回り
-
PER
-71.85
1 株当たり利益 (EPS)
-0.02
歳入
61.64M
純利益
-7.57M

Innate Pharma について

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
本社
Marseille, Bouches-du-rhone, Fra
設立
-
Innate Pharma is listed in the Biological Pds,ex Diagnstics sector of the ユーロネクスト with ticker IPH. The last closing price for Innate Pharma was 1.71 €. Over the last year, Innate Pharma shares have traded in a share price range of 1.332 € to 2.79 €.

Innate Pharma currently has 318,170,508 shares in issue. The market capitalisation of Innate Pharma is 544.71 € million. Innate Pharma has a price to earnings ratio (PE ratio) of -71.85.

IPH 最新ニュース

Innate Pharma annonce l’organisation d’une conférence destinée aux analystes et investisseurs pour présenter sa stratégie dans le domaine des conjugués anticorps-médicaments

Innate Pharma présentera IPH4502, son programme conjugué anticorps-médicament (ADC) le plus avancé au stade clinique Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) («...

Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 31 décembre 2024

Regulatory News: Conformément aux articles L. 233-8 II du Code de Commerce et 223-16 du règlement général de l’Autorité des marchés financiers (l’« AMF »), Innate Pharma SA (Euronext Paris : IPH...

Innate Pharma annonce une stratégie de transformation pour accélérer sa croissance

 Une stratégie axée sur le développement clinique précoce de molécules propriétaires présentant un potentiel en monothérapie : Stimuler l’innovation grâce à la plateforme ANKET® produisant des «...

Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that its management will present and host 1x1 meetings at the 43rd Annual J.P...

Innate Pharma présente à l’ASH 2024 des données de l’étude de Phase 2 TELLOMAK sur l’amélioration de la qualité de vie chez des patients atteints de lymphomes T cutanés

Les résultats mettent en évidence des signes précoces prometteurs selon lesquels lacutamab pourrait aider à soulager certains des symptômes les plus éprouvants des lymphomes T cutanés...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.04-2.288329519451.7481.771.702535941.72695964DE
4-0.242-12.41025641031.952.021.702860331.81660124DE
12-0.002-0.1169590643271.712.491.3321558231.76632345DE
26-0.402-19.05213270142.112.491.332956071.81654785DE
52-0.812-32.22222222222.522.791.332821172.0269895DE
156-2.006-54.01184706523.7143.81.3321325082.63229041DE
260-5.002-74.54545454556.718.31.3322676623.99506906DE

IPH - Frequently Asked Questions (FAQ)

What is the current Innate Pharma share price?
The current share price of Innate Pharma is 1.708 €
How many Innate Pharma shares are in issue?
Innate Pharma has 318,170,508 shares in issue
What is the market cap of Innate Pharma?
The market capitalisation of Innate Pharma is EUR 544.71M
What is the 1 year trading range for Innate Pharma share price?
Innate Pharma has traded in the range of 1.332 € to 2.79 € during the past year
What is the PE ratio of Innate Pharma?
The price to earnings ratio of Innate Pharma is -71.85
What is the cash to sales ratio of Innate Pharma?
The cash to sales ratio of Innate Pharma is 8.83
What is the reporting currency for Innate Pharma?
Innate Pharma reports financial results in EUR
What is the latest annual turnover for Innate Pharma?
The latest annual turnover of Innate Pharma is EUR 61.64M
What is the latest annual profit for Innate Pharma?
The latest annual profit of Innate Pharma is EUR -7.57M
What is the registered address of Innate Pharma?
The registered address for Innate Pharma is 117 AVENUE DE LUMINY, BP 30191, MARSEILLE, BOUCHES-DU-RHONE, 13009
What is the Innate Pharma website address?
The website address for Innate Pharma is www.innate-pharma.com
Which industry sector does Innate Pharma operate in?
Innate Pharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
MLCOTCoretech 5
0.021 €
(61.54%)
102.18k
AELISAelis Farma SA
3.36 €
(46.09%)
24.42k
ALIMOGroupimo
0.182 €
(43.31%)
484
ALCWECharwood Energy SA
3.14 €
(36.52%)
10.6k
FPGUnion Tech Info
0.268 €
(26.42%)
11.65k
DMSBSDiagnostic Medical Systems
0.0045 €
(-35.71%)
818
ALTROTronic s Microsystems
3.90 €
(-28.44%)
23
ALNMRNamR SA
0.344 €
(-28.33%)
90.71k
GNROGeNeuro SA
0.1625 €
(-27.46%)
1.06M
ALOKWGroupe Okwind SA
3.30 €
(-20.29%)
35.38k
ATOAtos SE
0.0021 €
(0.00%)
1.18B
BCPBanco Comercial Portugues SA
0.5154 €
(-0.62%)
61.83M
ALCYBCybergun
0.0001 €
(0.00%)
56.47M
ALVERVergnet
0.0014 €
(0.00%)
19.39M
EDPEDP SA
2.901 €
(-0.65%)
13.72M

最近閲覧した銘柄

Delayed Upgrade Clock